Xavier Reveles
Net worth: 2 335 $ as of 2026-05-30
Net worth: 2 335 $ as of 2026-05-30
Mr. Xavier T.
Reveles is a Chief Operating Officer at bioAffinity Technologies, Inc., a Director-Cytogenetics Laboratory at University of Texas Health Science Center At San Antonio and a Member at Association for Molecular Pathology.
Mr. Reveles was previously employed as a Laboratory Director by Oncopath Laboratory.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-01-09 | 1,398 ( 0.03% ) | 2 335 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| BIOAFFINITY TECHNOLOGIES, INC. | Chief Operating Officer | 2016-12-31 |
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Corporate Officer/Principal | - |
University of Texas Health Science Center At San Antonio
University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
Oncopath Laboratory | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Health Technology |
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
University of Texas Health Science Center At San Antonio
University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopath Laboratory |
Select your edition
All financial news and data tailored to specific country editions